Seizure recurrence after a first unprovoked seizure:With and without treatment

<ul> <li><strong>BACKGROUND</strong>: Most of the studies have shown that approximately one third of patients with single seizure will experience a second one. Data regarding seizure-free survival time and recurrence rate vary widely. We invest...

Full description

Bibliographic Details
Main Authors: Mohammad Reza Najafi, Ali Mehrabi, Farideh Najafi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-08-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://journals.mui.ac.ir/jrms/article/view/1006
id doaj-81657879a151419a890bc353cbe5cc9a
record_format Article
spelling doaj-81657879a151419a890bc353cbe5cc9a2020-11-25T00:26:13ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362008-08-01134161165Seizure recurrence after a first unprovoked seizure:With and without treatmentMohammad Reza NajafiAli MehrabiFarideh Najafi<ul> <li><strong>BACKGROUND</strong>: Most of the studies have shown that approximately one third of patients with single seizure will experience a second one. Data regarding seizure-free survival time and recurrence rate vary widely. We investigated the likelihood of a second attack and seizure-free survival time with and without early treatment in our epileptic patients.</li> <li><strong>METHODS</strong>: Patients of the first unprovoked seizures were recruited between 2000-2005 years. They were randomized into two groups: one treated with carbamazepine and the other was not treated. After obtaining a written consent, all patients were followed up for a second seizure for a period ranging from 12 to 36 (19.1 ± 5) months.</li> <li><strong>RESULTS</strong>: A total number of 150 patients were enrolled in this study, of which 13 patients were lost to follow up. The remaining patients (71 males and 66 females) were followed up during 5 years. They were randomized into two groups: treatment (50 patients) and non-treatment (87 patients); 30.2% of all patients were without relapsing, of which 48.9% were on treatment (case) and 19.5% did not receive any treatment (the control group). The mean seizure-free survival times were 6 months and 3.8 months in the treated and non-treated patients, respectively (P = 0.017).</li> <li><strong>CONCLUSIONS</strong>: We found strong correlation between relapse and treatment started after the first attack (P < 0.05); i.e., the patients who received treatment in their first attack may be at lower risk of relapsing.</li> <li><strong>KEY </strong><strong>WORDS: </strong>Unprovoked seizure, first seizure, recurrence, treatment, survival time.</li> </ul> http://journals.mui.ac.ir/jrms/article/view/1006Unprovoked seizure, first seizure, recurrence, treatment, survival time.
collection DOAJ
language English
format Article
sources DOAJ
author Mohammad Reza Najafi
Ali Mehrabi
Farideh Najafi
spellingShingle Mohammad Reza Najafi
Ali Mehrabi
Farideh Najafi
Seizure recurrence after a first unprovoked seizure:With and without treatment
Journal of Research in Medical Sciences
Unprovoked seizure, first seizure, recurrence, treatment, survival time.
author_facet Mohammad Reza Najafi
Ali Mehrabi
Farideh Najafi
author_sort Mohammad Reza Najafi
title Seizure recurrence after a first unprovoked seizure:With and without treatment
title_short Seizure recurrence after a first unprovoked seizure:With and without treatment
title_full Seizure recurrence after a first unprovoked seizure:With and without treatment
title_fullStr Seizure recurrence after a first unprovoked seizure:With and without treatment
title_full_unstemmed Seizure recurrence after a first unprovoked seizure:With and without treatment
title_sort seizure recurrence after a first unprovoked seizure:with and without treatment
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Medical Sciences
issn 1735-1995
1735-7136
publishDate 2008-08-01
description <ul> <li><strong>BACKGROUND</strong>: Most of the studies have shown that approximately one third of patients with single seizure will experience a second one. Data regarding seizure-free survival time and recurrence rate vary widely. We investigated the likelihood of a second attack and seizure-free survival time with and without early treatment in our epileptic patients.</li> <li><strong>METHODS</strong>: Patients of the first unprovoked seizures were recruited between 2000-2005 years. They were randomized into two groups: one treated with carbamazepine and the other was not treated. After obtaining a written consent, all patients were followed up for a second seizure for a period ranging from 12 to 36 (19.1 ± 5) months.</li> <li><strong>RESULTS</strong>: A total number of 150 patients were enrolled in this study, of which 13 patients were lost to follow up. The remaining patients (71 males and 66 females) were followed up during 5 years. They were randomized into two groups: treatment (50 patients) and non-treatment (87 patients); 30.2% of all patients were without relapsing, of which 48.9% were on treatment (case) and 19.5% did not receive any treatment (the control group). The mean seizure-free survival times were 6 months and 3.8 months in the treated and non-treated patients, respectively (P = 0.017).</li> <li><strong>CONCLUSIONS</strong>: We found strong correlation between relapse and treatment started after the first attack (P < 0.05); i.e., the patients who received treatment in their first attack may be at lower risk of relapsing.</li> <li><strong>KEY </strong><strong>WORDS: </strong>Unprovoked seizure, first seizure, recurrence, treatment, survival time.</li> </ul>
topic Unprovoked seizure, first seizure, recurrence, treatment, survival time.
url http://journals.mui.ac.ir/jrms/article/view/1006
work_keys_str_mv AT mohammadrezanajafi seizurerecurrenceafterafirstunprovokedseizurewithandwithouttreatment
AT alimehrabi seizurerecurrenceafterafirstunprovokedseizurewithandwithouttreatment
AT faridehnajafi seizurerecurrenceafterafirstunprovokedseizurewithandwithouttreatment
_version_ 1725345357795164160